MedTrace Logo

Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males

NCT01514578 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2012-08-24

No results posted yet for this study

Summary

This study will evaluate the safety, blood levels, and effects of TRV130A on pain perception and sedation in healthy adult males.

Conditions

  • Healthy

Interventions

DRUG

TRV130A

Intravenous infusion of 1 hour duration

DRUG

Dextrose in Water

Intravenous infusion of 1 hour duration

Sponsors & Collaborators

  • Trevena Inc.

    lead INDUSTRY

Principal Investigators

  • David G. Soergel, MD · Trevena Inc.

  • Alan S. Marion, MD, PhD · ICON Development Solutions

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01514578 on ClinicalTrials.gov